DEFECTIVE DRUGS
Parker Waichman Alonso LLP is a leader in a defective drug litigation. We are currently evaluating cases involving the prescription drugs listed below. Please click on a specific drug or fill out the form at the right for a free case evaluation by a qualified attorney.
Defective Drugs
Defective Drugs NewsRSS Feed
Cancer, Infections Reported in Kids Treated with Elidel, Protopic
Mar 19, 2010 | Parker Waichman Alonso LLP
Dozens of cancer cases and infections have been reported in children treated with the eczema drugs Elidel and Protopic. According to a report from...
FDA Says High Dose of Zocor Linked to Serious Muscle Injury
Mar 19, 2010 | Parker Waichman Alonso LLP
Federal regulators warned today against taking the highest approved dose - 80 mg - of the statin Zocor (simvastatin). According to the ...
More Cleviprex Recalled Over Particulate Matter
Mar 18, 2010 | Parker Waichman Alonso LLP
The Medicines Company has expanded a recall of Cleviprex injectable emulsion it announced this past December. Four more lots are now included. ...
Procter & Gamble Cautions on Zinc in Fixodent
Mar 17, 2010 | Parker Waichman Alonso LLP
Without much fanfare, Procter & Gamble has begun cautioning consumers about zinc in Fixodent denture creams on it Web site,...
New Black Box Warning for Plavix
Mar 15, 2010 | Parker Waichman Alonso LLP
The Food & Drug Administration (FDA) is adding a Black Box Warning to the Plavix label because the drug may not be effective in certain...
Fosamax, Other Osteoporosis Drugs, Raise Concerns Over Femur Fractures
Mar 11, 2010 | Parker Waichman Alonso LLP
There are more concerns today that Fosamax, Actonel, Boniva, and Reclast, a class of drugs known as oral bisphosphonates that are used to...
Yaz, Yasmin Named in Canadian Lawsuit
Mar 11, 2010 | Parker Waichman Alonso LLP
Some Canadian women have filed suit against the maker of the Yaz and Yasmin birth control pills, claiming Bayer did not adequately warn about higher...
Avandia Could Cost Glaxo Big
Mar 9, 2010 | Parker Waichman Alonso LLP
Avandia lawsuits could end up costing GlaxoSmithKline as much as $6 billion, according to a UBS analyst. In a note made public last Friday, the...
Poligrip with Zinc Recalled In Japan. Why Not U.S.?
Mar 8, 2010 | Parker Waichman Alonso LLP
Following drug maker, GlaxoSmithKline’s, announcement last month that it is no longer making, distributing, or issuing...
Avandia, Seroquel Have Most Adverse Event Report
Mar 5, 2010 | Parker Waichman Alonso LLP
Avandia’s cardiovascular problems have long been the subject of concern and controversy. Now, reports FiercePharma, an adverse...
Merck Loses Australian Vioxx Lawsuit
Mar 5, 2010 | Parker Waichman Alonso LLP
We just wrote that Merck & Co. made a final $4.1 billion payment to its Vioxx settlement fund. According to a recent Associated...
ADA Issues Statement on Zinc in Denture Creams
Mar 2, 2010 | Parker Waichman Alonso LLP
The American Dental Association (ADA) has weighed in on the controversy surrounding zinc-containing denture creams. In a statement issued...


